Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.3 was added to the study record's version history, and the previous revision v3.6.2 was removed, updating the historical record for the study.
    Difference
    0.1%
    Check dated 2026-07-05T13:57:23.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision label v3.6.2 was added to the study record history, and the older v3.6.0 entry was removed from the log.
    Difference
    0.1%
    Check dated 2026-06-28T08:25:52.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Enrollment is closed to new participants, reflecting a recruitment-status update on the study page. The record has been updated to include the latest revision tag v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T03:59:21.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    New revision v3.5.5 was added to the revision history, replacing the previous v3.5.4. This update signifies an administrative change to the page's version record rather than content changes.
    Difference
    0.1%
    Check dated 2026-06-06T22:37:05.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.5.3 to v3.5.4, indicating a newer release of the page's interface. This is a UI/system update rather than substantive changes to the study record or its data.
    Difference
    0.1%
    Check dated 2026-05-16T10:07:02.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov interface revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site tooling update rather than a change to the trial’s record data.
    Difference
    0.1%
    Check dated 2026-04-24T22:42:43.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.